RT Journal Article
SR Electronic
T1 Gait differences in patients with multiple sclerosis who have low and high levels of disability
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19000166
DO 10.1101/19000166
A1 John J. Fraser
A1 Jeannie B. Stephenson
YR 2019
UL http://medrxiv.org/content/early/2019/06/25/19000166.abstract
AB Background Multiple Sclerosis (MS) often results in gait impairment and disability.Objective To investigate differences in spatiotemporal gait characteristics of people with MS who have low versus high levels of disability. Between trial and inter-limb consistency and the association of gait variables with level of disability were also investigated.Methods Participants with MS who had either low-disability [n=7; 3 females; EDSS mean: 2.7±0.5, range 2.0-4.5; BMI=26.9±6.6] or high-disability [n=11; 6 females; EDSS mean: 2.7±0.5, range 6.0-6.5; BMI=27.8±1.5) performed 2 trials of self-selected walking on an instrumented walkway. Differences in group, limb, and group by limb interactions were assessed using analysis of variance, independent-measures t-tests, and Cohen’s d effect sizes (ES). Between-trial consistency of gait were assessed with intra-class correlation coefficients (2, k).Results Participants in the high disability group had increased step time (ES=0.8), cycle time (ES=0.8), and ambulation time (ES=1.2) while taking shorter strides (ES=0.9) and more steps at a slower rate (ES=1.1). The high disability group demonstrated less between-trial consistency for 69% of gait variables when compared to the low disability group.Conclusion People with MS who have high levels of disability walk differently and with less consistency than those with lower levels of disability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.NAI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesData will be provided upon request.